The Indianapolis Life Sciences company is developing a new drug to treat migraines. Having just released positive results from its latest study, the company's first-in-its-class new migraine drug is still in the development phase, but the latest trials show it to be safe and effective. Barbara Lewis talks with CEO Jim White. Learn more at http://www.colucid.com/